AGP Executive Report
Last update: 9 hours agoBrain Health Breakthrough: Kazakhstan opened Central Asia’s first specialized Brain Research Institute at Al-Farabi KazNU in Almaty, aiming to boost neuroscience research and training using advanced MRI and EEG tools plus AI-assisted medical studies. Diabetes Update: Kazakhstan reported a drop in overall diabetes incidence in Q1 2026 (308.7 per 100,000 vs 313.5 in Q1 2025), citing stronger endocrinology services and more prevention work in primary care. Maternal Care Gains: Maternal mortality fell 43% in the first quarter of 2026 (6.8 vs 12.0 per 100,000 live births), alongside improved early pregnancy monitoring and expanded perinatal center renovation plans. Pharma Investment Surge: Investment in Kazakhstan’s pharmaceutical and medical device manufacturing hit $142.8m in 2025—over triple 2023—supporting modernization, capacity expansion, and localization. Student Tragedy Abroad: Two Indian MBBS students drowned while swimming in Kazakhstan; FAIMA has asked India’s MEA and the embassy for urgent help repatriating the bodies. Public Health & Safety: A deadly Kazzinc plant blast in eastern Kazakhstan was preliminarily linked to violations of technological procedures, with investigations continuing after three workers died.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.